Tab.terbinafine 250mg
Tender Title | Tab.terbinafine 250mg | ||
Tender ID | NA | Tender Reference Number | 78245354 |
Tender Type | Limited | ||
Tender Opening Date | 2024-09-03 02:07 AM | Tender Closing Date | 2024-09-20 05:00 AM |
Tender Value | Refer Document | Tender Location | Bilaspur , Bilaspurcgh , Chhattisgarh |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2024-09-03 02:07 AM | Bid Opening Date | 2024-09-20 05:00 AM |
Document Download Start Date | 2024-09-03 02:07 AM | Document Download End Date | 2024-09-20 05:00 AM |
Bid Submission Start Date | 2024-09-03 02:07 AM | Bid Submission End Date | 2024-09-20 05:00 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | Refer document |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, Southeast Central Railway, is inviting bids for the supply of TAB.TERBINAFINE 250MG, a railway related product. This limited tender, with a reference number of 78245354, seeks to procure these goods for the Divisional Medical Stores/SECR/NGP Nagpur. The tender documents can be downloaded starting on September 3rd, 2024 at 7:37 AM and bids must be submitted by 10:30 AM on September 20th, 2024. The tender fee and earnest money deposit are both waived for this procurement. For complete details on the requirements and specifications, please refer to the tender document.
Office Inviting Bids | Secr-hosp-ngp-medical/south East Central Rly |
Address | Divisional Medical Stores/secr/ngp Nagpur |
Contact Details | NA |
NA | |
Website | NA |
Tab. Tranexamic Acid 500mgmefenamicacid 250mg..read more
(1)ergotamine Tartarate 1mg ,caffeine 100mg,paracetamol 250mg Tablet (2)ergotamine Tartarate 1mg ,caffeine 100mg, Prochlorperazine Maleate 2.5mg Paracetamol 250mg Tablet...read more
Paracetamol (250mg/5ml) Syrup, Bottle Of Minimum 60ml..read more